Effect of oral naltrexone on pruritus in cholestatic patients

World Journal of Gastroenterology : WJG
Fariborz Mansour-GhanaeiZahra Pourrasouli

Abstract

To determine the efficacy and potential complications of oral naltrexone used in the treatment of pruritus in cholestatic patients and to compare them with other studies. Thirty-four enrolled cholestatic patients complaining of pruritus were studied. In the initial phase, pruritus scores during day and night were evaluated. Subsequently, patients were given a placebo for one week followed by naltrexone for one week. In each therapeutic course (placebo or naltrexone) day and night pruritus scores were distinguished by a visual analogue scale (VAS) system and recorded in patients' questionnaires. Both naltrexone and placebo decreased VAS scores significantly. Naltrexone was more effective than placebo in decreasing VAS scores. Both day and night scores of pruritus decreased by half of the value prior to therapy in thirteen patients (38%). Daytime pruritus improved completely in two patients (5.9%), but no improvement in the nighttime values was observed in any patient. Sixteen patients (47%) suffered from naltrexone complications, eleven (32%) of them were related to its withdrawal. Complications were often mild. In the case of withdrawal, the complication was transient (within the first 24-28 h of therapy) and self-limited. We h...Continue Reading

References

Feb 1, 1991·Digestive Diseases and Sciences·A PodestaJ P Companc
May 1, 1990·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·E A Jones, N V Bergasa
Apr 1, 1990·Gastroenterology·H A CynamonR P Iafrate
Oct 1, 1989·Gut·J R Thornton, M S Losowsky
Jun 29, 1989·The New England Journal of Medicine·B H MarkusT E Starzl
May 24, 1986·Lancet·J E Mitchell
Nov 1, 1988·Psychological Medicine·H M McCormackS Sheather
Dec 10, 1988·BMJ : British Medical Journal·J R Thornton, M S Losowsky
Mar 1, 1985·Gut·L B CohenF Schaffner
Mar 1, 1972·Gut·G M MurphyB H Billing
Sep 1, 1994·Journal of Clinical Pharmacology·D S SaxA Kim
May 12, 1994·The New England Journal of Medicine·R E PouponB Balkau
Jan 1, 1994·Digestive Diseases and Sciences·M Khandelwal, P F Malet
Nov 1, 1993·Seminars in Liver Disease·N V Bergasa, E A Jones
Jun 1, 1993·Gastroenterology·D M Heuman
Oct 6, 1997·Journal of Hepatology·M BertolottiE Sternieri
Mar 21, 1998·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·N V BergasaE A Jones
Nov 24, 1998·The Annals of Pharmacotherapy·S G Terra, S M Tsunoda
Mar 30, 1999·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·E A Jones, N V Bergasa
Jul 27, 1999·European Journal of Gastroenterology & Hepatology·E A Jones, N V Bergasa
Mar 25, 2000·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·E J Heathcote
Apr 24, 2001·Addictive Behaviors·J M SchmitzJ Grabowski
May 21, 2003·Journal of Paediatrics and Child Health·M YeoS M Sawyer
Aug 2, 2003·Gastroenterology·Christine A McRaeDavid E J Jones
Jul 15, 2004·Alcoholism, Clinical and Experimental Research·Henry R KranzlerUNKNOWN DrugAbuse Sciences Naltrexone Depot Study Group
Oct 6, 2004·Expert Opinion on Pharmacotherapy·Darlene H Moak
Nov 2, 2004·Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete·A BruneS Ständer
Apr 9, 2005·Alimentary Pharmacology & Therapeutics·J W O'DonohueR Williams

❮ Previous
Next ❯

Citations

Dec 12, 2007·Experimental Dermatology·Sonja StänderThomas A Luger
Jan 27, 2009·The Journal of Pharmacology and Experimental Therapeutics·Joel E SchlosburgAron H Lichtman
Oct 13, 2009·Journal of Gastroenterology and Hepatology·Sombat TreeprasertsukPolrat Wilairatana
Jul 7, 2018·Health and Quality of Life Outcomes·Fatima IsaMelanie Calvert
Jun 26, 2009·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Keith D LindorUNKNOWN American Association for Study of Liver Diseases
Dec 3, 2015·Expert Opinion on Pharmacotherapy·Carolyn StullGil Yosipovitch
Mar 20, 2019·Current Drug Targets·Mariusz SikoraLidia Rudnicka
Aug 28, 2019·Experimental Dermatology·Andreas E Kremer
Jun 3, 2009·Journal of Gastroenterology and Hepatology·Negar FaramarziAhmad R Dehpour
Sep 21, 2013·The Journal of Pediatric Pharmacology and Therapeutics : JPPT : the Official Journal of PPAG·Sarah Dillon, Joseph D Tobias
Apr 30, 2010·Expert Opinion on Pharmacotherapy·Tejesh Patel, Gil Yosipovitch
Jun 10, 2017·World Journal of Gastroenterology : WJG·Kazuto Tajiri, Yukihiro Shimizu
May 8, 2008·Nature Clinical Practice. Neurology·Andreas BinderRalf Baron
Nov 17, 2016·The Cochrane Database of Systematic Reviews·Waldemar SiemensGerhild Becker
Oct 9, 2020·Gastroenterology·Elsemieke de VriesUNKNOWN Netherlands Association for the Study of the Liver-Cholestasis Working Group
Sep 9, 2020·Biochimica Et Biophysica Acta. Molecular Basis of Disease·Babina Sanjel, Won-Sik Shim
Mar 12, 2021·BMJ Supportive & Palliative Care·Fay Louise Murray-Brown
Apr 2, 2021·Frontiers in Medicine·Jacqueline A G M LangedijkRonald P J Oude Elferink
May 14, 2010·Journal of the American Academy of Dermatology·Ngoc Quan PhanSonja Ständer

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of the European Academy of Dermatology and Venereology : JEADV
F MalekzadS Nasiri
American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
Jeffrey J Cies, John N Giamalis
Anales de medicina interna : organo oficial de la Sociedad Española de Medicina Interna
F Lamelo AlfonsínM Silva César
© 2021 Meta ULC. All rights reserved